MINT-BRIVARACETAM
As listed in the register: MINT-BRIVARACETAM
75 mg · tablet
- Prescription only
- Pain, sleep, mood, epilepsy and the brain
- Active substance
- Brivaracetam
- Made by
- Mint Pharmaceuticals Inc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Briviact). It describes the substance, not this exact product.
The precise mechanism by which BRIVIACT exerts its anticonvulsant activity is not known.
Brivaracetam displays a high and selective affinity for synaptic vesicle protein 2A (SV2A) in the brain, which may contribute to the anticonvulsant effect.
Brivaracetam is primarily metabolized by hydrolysis of the amide moiety to form the corresponding carboxylic acid metabolite, and secondarily by hydroxylation on the propyl side chain to form the hydroxy metabolite.
Brivaracetam is eliminated primarily by metabolism and by excretion in the urine.
The median T max for tablets taken without food is 1 hour (range 0.25 to 3 hours).
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-08-20
Safety of the active substance
From the US prescribing label for the same active substance (Briviact). It describes the substance, not this exact product.
- Hypersensitivity to brivaracetam or any of the inactive ingredients in BRIVIACT (bronchospasm and angioedema have occurred) [see Warnings and Precautions (5.4) ].
Most common adverse reactions are similar to those seen in adult patients.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States10 matching products
European UnionNo exact match for this strength and form
Spain15 matching products
- BRIVIACT 75 mg · comprimido recubierto con película2 makers
- BRIVARACETAM CINFA 75 mg · comprimido recubierto con película
- BRIVARACETAM COMBIX 75 mg · comprimido recubierto con película
- BRIVARACETAM DESITIN 75 mg · comprimido recubierto con película
- BRIVARACETAM PENSA 75 mg · comprimido recubierto con película
- BRIVARACETAM SANDOZ 75 mg · comprimido recubierto con película
- BRIVARACETAM SKM 75 mg · comprimido recubierto con película
- BRIVARACETAM STADA 75 mg · comprimido recubierto con película
Netherlands9 matching products
- Brivaracetam Amarox 75 mg filmomhulde tabletten 75 mg · filmomhulde tablet
- Brivaracetam Glenmark 75 mg filmomhulde tabletten 75 mg · filmomhulde tablet
- Brivaracetam Sandoz 75 mg 75 mg · filmomhulde tablet
- Brivaracetam STADA 75 mg 75 mg · filmomhulde tablet
- Brivaracetam Teva 75 mg 75 mg · filmomhulde tablet
- Brivaracetam Vivanta 75 mg filmomhulde tabletten 75 mg · filmomhulde tablet
- Brivaracetam Xiromed 75 mg filmomhulde tabletten 75 mg · filmomhulde tablet
- Briviact 75 mg 75 mg · filmomhulde tablet
SwitzerlandNo exact match for this strength and form
Details
| Made by | Mint Pharmaceuticals Inc |
|---|---|
| Active substance | Brivaracetam |
| Used in | Pain, sleep, mood, epilepsy and the brain |
| Strength | 75 mg |
| Form | tablet |
| Classification | N03AX23 · Pain, sleep, mood, epilepsy and the brain |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Approved |
| Marketed | No — authorised but not currently marketed, according to the register |
| DIN | 02569647 |
| DPD drug code | 107187 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
5 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.